Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study.

Antoniou K, Markopoulou K, Tzouvelekis A, Trachalaki A, Vasarmidi E, Organtzis J, Tzilas V, Bouros E, Kounti G, Rampiadou C, Kotoulas SC, Bardaka F, Bibaki E, Fouka E, Meletis G, Tryfon S, Daniil Z, Papakosta D, Bouros D.

ERJ Open Res. 2020 Jan 27;6(1). pii: 00172-2019. doi: 10.1183/23120541.00172-2019. eCollection 2020 Jan.

2.

Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.

Tzouvelekis A, Karampitsakos T, Gomatou G, Bouros E, Tzilas V, Manali E, Tomos I, Trachalaki A, Kolilekas L, Korbila I, Tomos P, Chrysikos S, Gaga M, Daniil Z, Bardaka F, Papanikolaou IC, Euthymiou C, Papakosta D, Steiropoulos P, Ntolios P, Tringidou R, Papiris S, Antoniou K, Bouros D.

Pulm Pharmacol Ther. 2020 Feb;60:101880. doi: 10.1016/j.pupt.2019.101880. Epub 2019 Dec 23.

PMID:
31874284
3.

Interstitial Lung Abnormalities: A Word of Caution.

Tzilas V, Bouros D.

Chest. 2019 Dec;156(6):1037-1038. doi: 10.1016/j.chest.2019.08.2170. No abstract available.

PMID:
31812187
4.

A 63-Year-Old Woman With Pulmonary Micronodules and Chronic Cough.

Tzilas V, Kyriazis P, Tzouvelekis A, Vachlas K, Frangia K, Bouros D.

Chest. 2019 Aug;156(2):e47-e50. doi: 10.1016/j.chest.2019.03.034.

PMID:
31395268
5.

Autoimmune Biomarkers, Antibodies, and Immunologic Evaluation of the Patient with Fibrotic Lung Disease.

Tzouvelekis A, Karampitsakos T, Bouros E, Tzilas V, Liossis SN, Bouros D.

Clin Chest Med. 2019 Sep;40(3):679-691. doi: 10.1016/j.ccm.2019.06.002. Review.

PMID:
31376900
6.

Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern.

Tzilas V, Tzouvelekis A, Bouros E, Karampitsakos T, Ntasiou M, Katsaras M, Costabel U, Wells A, Bouros D.

Eur Respir J. 2019 Nov 14;54(5). pii: 1901144. doi: 10.1183/13993003.01144-2019. Print 2019 Nov. No abstract available.

PMID:
31320457
7.

Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer.

Tzouvelekis A, Gomatou G, Bouros E, Trigidou R, Tzilas V, Bouros D.

Chest. 2019 Aug;156(2):383-391. doi: 10.1016/j.chest.2019.04.114. Epub 2019 May 22. Review.

PMID:
31125557
8.

Human pentraxin 2 protein treatment for IPF.

Tzouvelekis A, Tzilas V, Antoniou KM, Bouros D.

Lancet Respir Med. 2019 Aug;7(8):640-641. doi: 10.1016/S2213-2600(19)30173-0. Epub 2019 May 20. No abstract available.

PMID:
31122900
9.

Safety and Efficacy of Early and Long-Term Use of Pirfenidone in Idiopathic Pulmonary Fibrosis.

Tzilas V, Tzouvelekis A, Bouros D.

Respiration. 2019;98(1):16-18. doi: 10.1159/000497391. Epub 2019 Apr 4. No abstract available.

PMID:
30947205
10.

Interstitial lung abnormalities: ignotum per ignotius.

Antoniou KM, Tzilas V, Vasarmidi E, Symvoulakis EK, Tzouvelekis A, Bouros D.

Lancet Respir Med. 2019 May;7(5):376-378. doi: 10.1016/S2213-2600(19)30052-9. Epub 2019 Mar 29. No abstract available.

PMID:
30935882
11.

Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?

Kolilekas L, Costabel U, Tzouvelekis A, Tzilas V, Bouros D.

Eur Respir J. 2019 Feb 14;53(2). pii: 1800994. doi: 10.1183/13993003.00994-2018. Print 2019 Feb. No abstract available.

PMID:
30765482
12.

Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis.

Tzilas V, Bouros E, Barbayianni I, Karampitsakos T, Kourtidou S, Ntassiou M, Ninou I, Aidinis V, Bouros D, Tzouvelekis A.

Pulm Pharmacol Ther. 2019 Apr;55:17-24. doi: 10.1016/j.pupt.2019.01.003. Epub 2019 Jan 16.

PMID:
30659895
13.

Crazy paving pattern as a rare radiological manifestation of peripheral T-cell lymphoma (PTCL) with lung involvement: A case report.

Gomatou G, Tzilas V, Kourti G, Lagou S, Bouros D, Syrigos K.

Respir Med Case Rep. 2018 Sep 26;25:253-256. doi: 10.1016/j.rmcr.2018.09.015. eCollection 2018.

14.

Diagnostic guidelines for IPF: when art meets science.

Bouros D, Tzilas V, Tzouvelekis A.

Lancet Respir Med. 2018 Nov;6(11):812-814. doi: 10.1016/S2213-2600(18)30430-2. No abstract available.

PMID:
30484427
15.

Metformin in Idiopathic Pulmonary Fibrosis "Seeking the Holy-Grail through Drug-Repositioning".

Tzouvelekis A, Tzilas V, Dassiou M, Bouros D.

Respiration. 2018;96(4):305-307. doi: 10.1159/000490917. Epub 2018 Jul 13. No abstract available.

16.

Prognosis of Interstitial Lung Disease Associated with Anti-Aminoacyl-tRNA Synthetase Antibodies: Look in the Middle.

Tzilas V, Tzouvelekis A, Bouros E, Bouros D.

Respiration. 2018;96(3):207-209. doi: 10.1159/000489936. Epub 2018 Jun 19. No abstract available.

17.

Metabolic Disorders in Chronic Lung Diseases.

Papaioannou O, Karampitsakos T, Barbayianni I, Chrysikos S, Xylourgidis N, Tzilas V, Bouros D, Aidinis V, Tzouvelekis A.

Front Med (Lausanne). 2018 Jan 18;4:246. doi: 10.3389/fmed.2017.00246. eCollection 2017. Review.

18.

Corrigendum: Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.

Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Markozannes E, Malliou I, Anagnostopoulos A, Granitsas A, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D.

Front Med (Lausanne). 2018 Jan 24;4:257. doi: 10.3389/fmed.2017.00257. eCollection 2017.

19.

Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece.

Tzouvelekis A, Karampitsakos T, Kontou M, Granitsas A, Malliou I, Anagnostopoulos A, Ntolios P, Tzilas V, Bouros E, Steiropoulos P, Chrysikos S, Dimakou K, Koulouris N, Bouros D.

Pulm Pharmacol Ther. 2018 Apr;49:61-66. doi: 10.1016/j.pupt.2018.01.006. Epub 2018 Jan 31.

PMID:
29366978
20.

Patients with IPF and lung cancer: diagnosis and management.

Tzouvelekis A, Spagnolo P, Bonella F, Vancheri C, Tzilas V, Crestani B, Kreuter M, Bouros D.

Lancet Respir Med. 2018 Feb;6(2):86-88. doi: 10.1016/S2213-2600(17)30478-2. Epub 2017 Dec 11. Review. No abstract available.

PMID:
29241977
21.

Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.

Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Markozannes E, Malliou I, Anagnostopoulos A, Granitsas A, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D.

Front Med (Lausanne). 2017 Nov 29;4:213. doi: 10.3389/fmed.2017.00213. eCollection 2017. Erratum in: Front Med (Lausanne). 2018 Jan 24;4:257.

22.

Taking a giant step in the diagnosis of idiopathic pulmonary fibrosis.

Tzilas V, Valeyre D, Tzouvelekis A, Bouros D.

Lancet Respir Med. 2018 Feb;6(2):82-84. doi: 10.1016/S2213-2600(17)30443-5. Epub 2017 Nov 15. No abstract available.

PMID:
29154105
23.

Metsovo Lung: A Story of Episteme, Techne, and Phronesis.

Tzilas V, Tzouvelekis A, Bouros D.

Respiration. 2017;94(6):491-492. doi: 10.1159/000481291. Epub 2017 Oct 13. No abstract available.

24.

Diagnosis of Idiopathic Pulmonary Fibrosis "Pragmatic Challenges in Clinical Practice".

Tzilas V, Tzouvelekis A, Chrysikos S, Papiris S, Bouros D.

Front Med (Lausanne). 2017 Sep 20;4:151. doi: 10.3389/fmed.2017.00151. eCollection 2017. Review.

25.

Pirfenidone in Idiopathic Pulmonary Fibrosis "RECAP-itulating Safety into the Real World".

Tzouvelekis A, Bouros E, Tzilas V, Bouros D.

Respiration. 2017;94(5):405-407. doi: 10.1159/000480299. Epub 2017 Sep 5. No abstract available.

26.

Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study.

Tzouvelekis A, Ntolios P, Karampitsakos T, Tzilas V, Anevlavis S, Bouros E, Steiropoulos P, Koulouris N, Stratakos G, Froudarakis M, Bouros D.

Pulm Pharmacol Ther. 2017 Oct;46:48-53. doi: 10.1016/j.pupt.2017.08.011. Epub 2017 Aug 24.

PMID:
28843616
27.

Dissecting Survival Pathways in Lung Cancer, Fibrosis and Emphysema: "The Four Horses of the Apocalypse".

Tzouvelekis A, Tzilas V, Papiris S, Bouros D.

Respiration. 2017;94(3):239-241. doi: 10.1159/000478910. Epub 2017 Jul 19. No abstract available.

28.

Guidelines for Idiopathic Pulmonary Fibrosis: Everything Flows.

Tzilas V, Bouros E, Tzouvelekis A, Bouros D.

Respiration. 2017;93(6):401-403. doi: 10.1159/000473884. Epub 2017 Apr 27. No abstract available.

29.

Lung cancer in patients with idiopathic pulmonary fibrosis.

Karampitsakos T, Tzilas V, Tringidou R, Steiropoulos P, Aidinis V, Papiris SA, Bouros D, Tzouvelekis A.

Pulm Pharmacol Ther. 2017 Aug;45:1-10. doi: 10.1016/j.pupt.2017.03.016. Epub 2017 Apr 1. Review.

PMID:
28377145
30.

Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis: A patient's "Q and A" approach.

Tzouvelekis A, Tzilas V, Papiris S, Aidinis V, Bouros D.

Pulm Pharmacol Ther. 2017 Feb;42:21-24. doi: 10.1016/j.pupt.2016.12.002. Epub 2016 Dec 12. Review.

PMID:
27979760
31.

Usual interstitial pneumonia pattern in the diagnosis of idiopathic pulmonary fibrosis?

Tzilas V, Bouros D.

Lancet Respir Med. 2016 Oct;4(10):770-772. doi: 10.1016/S2213-2600(16)30231-4. No abstract available.

PMID:
27707457
32.

Idiopathic Pulmonary Fibrosis and Emphysema: Between Scylla and Charybdis.

Tzilas V, Tzouvelekis A, Papiris S, Bouros D.

Respiration. 2016;92(4):215-217. Epub 2016 Sep 8. No abstract available.

33.

The Six-Minute Stepper Test: Solvitur ambulando.

Tzilas V, Bouros D.

Respiration. 2016;91(6):469-70. doi: 10.1159/000447248. Epub 2016 Jun 22. No abstract available.

34.

Cardiopulmonary Exercise Testing in Systemic Sclerosis: 'Ars longa, vita brevis'.

Tzilas V, Bouros D.

Respiration. 2016;91(3):202-3. doi: 10.1159/000444091. Epub 2016 Feb 5. No abstract available.

35.

Inherent weaknesses of the current ICD coding system regarding idiopathic pulmonary fibrosis.

Tzilas V, Bouros D.

Eur Respir J. 2015 Apr;45(4):1194-6. doi: 10.1183/09031936.00205914. No abstract available.

36.

The "reversed halo" sign in pneumonococcal pneumonia: a review with a case report.

Tzilas V, Bastas A, Provata A, Koti A, Tzouda V, Tsoukalas G.

Eur Rev Med Pharmacol Sci. 2010 May;14(5):481-6. Review.

PMID:
20556929
37.

Persistent left superior vena cava mistaken for nodal metastasis: a case report.

Tzilas V, Bastas A, Koti A, Papandrinopoulou D, Tsoukalas G.

J Med Case Rep. 2010 Jun 9;4:174. doi: 10.1186/1752-1947-4-174.

38.

Prognostic factors in idiopathic pulmonary fibrosis.

Tzilas V, Koti A, Papandrinopoulou D, Tsoukalas G.

Am J Med Sci. 2009 Dec;338(6):481-5. doi: 10.1097/MAJ.0b013e3181ad5984. Review.

PMID:
19826245
39.

A rare cause of dysphagia--aberrant right subclavian artery (ARSA).

Tzilas V, Koti A, Tsoukalas G.

Eur Rev Med Pharmacol Sci. 2009 Jul-Aug;13(4):313-6.

PMID:
19694347
40.

A 77 year old male with peripheral eosinophilia, pulmonary infiltrates and a small pleural effusion.

Tzilas V, Bastas A, Koti A, Papandrinopoulou D, Tsoukalas G.

Eur Rev Med Pharmacol Sci. 2009 May-Jun;13(3):227-32. Review.

PMID:
19673174

Supplemental Content

Loading ...
Support Center